Effects of implantation of a deep brain stimulation device on patient weight in Parkinson's disease and essential tremor

Monteferrante NR, Wilhelmi BG, Lambert M, Ponce FA.

J Neurosurg. 2020 May 22:1-7. doi: 10.3171/2020.2.JNS192354. Online ahead of print.

Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner

Lancet Neurol. 2020 Jan;19(1):71-80. doi: 10.1016/S1474-4422(19)30319-9. Epub 2019 Oct 31.

Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial

Mullin S, Smith L, Lee K, D'Souza G, Woodgate P, Elflein J, Hällqvist J, Toffoli M, Streeter A, Hosking J, Heywood WE, Khengar R, Campbell P, Hehir J, Cable S, Mills K, Zetterberg H, Limousin P, Libri

JAMA Neurol. 2020 Apr 1;77(4):427-434. doi: 10.1001/jamaneurol.2019.4611.

Neuroanatomy, Extrapyramidal System

Lee J, Muzio MR.

2020 Jan 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–.

α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients

Manne S, Kondru N, Jin H, Anantharam V, Huang X, Kanthasamy A, Kanthasamy AG.

Mov Disord. 2020 Feb;35(2):268-278. doi: 10.1002/mds.27907. Epub 2019 Nov 23.

A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression

Niu M, Li Y, Li G, Zhou L, Luo N, Yao M, Kang W, Liu J.

Eur J Neurol. 2020 Jun;27(6):967-974. doi: 10.1111/ene.14208. Epub 2020 Apr 13.

The Neural Signature of Impaired Dual-Tasking in Idiopathic Rapid Eye Movement Sleep Behavior Disorder Patients

Ehgoetz Martens KA, Matar E, Shine JM, Phillips JR, Georgiades MJ, Grunstein RR, Halliday GM, Lewis SJG.

Mov Disord. 2020 Jun 11. doi: 10.1002/mds.28114. Online ahead of print.

α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model

Taguchi T, Ikuno M, Hondo M, Parajuli LK, Taguchi K, Ueda J, Sawamura M, Okuda S, Nakanishi E, Hara J, Uemura N, Hatanaka Y, Ayaki T, Matsuzawa S, Tanaka M, El-Agnaf OMA, Koike M, Yanagisawa M, Uemura

Brain. 2020 Jan 1;143(1):249-265. doi: 10.1093/brain/awz380.

Differentiating Parkinson's disease motor subtypes using automated volume-based morphometry incorporating white matter and deep gray nuclear lesion load

Fang E, Ann CN, Maréchal B, Lim JX, Tan SYZ, Li H, Gan J, Tan EK, Chan LL.

J Magn Reson Imaging. 2020 Mar;51(3):748-756. doi: 10.1002/jmri.26887. Epub 2019 Jul 31.

Stimulation of the tibial nerve: a protocol for a multicentred randomised controlled trial for urinary problems associated with Parkinson's disease-STARTUP

McClurg D, Panicker J, Walker RW, Cunnington A, Deane KHO, Harari D, Elders A, Booth J, Hagen S, Mason H, Stratton S.

BMJ Open. 2020 Feb 17;10(2):e034887. doi: 10.1136/bmjopen-2019-034887.

The cost-effectiveness of specialized nursing interventions for people with Parkinson's disease: the NICE-PD study protocol for a randomized controlled clinical trial

Radder DLM, Lennaerts HH, Vermeulen H, van Asseldonk T, Delnooz CCS, Hagen RH, Munneke M, Bloem BR, de Vries NM.

Trials. 2020 Jan 15;21(1):88. doi: 10.1186/s13063-019-3926-y.

Parkinson's disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging

Chen X, Xie C, Tian W, Sun L, Zheng W, Hawes S, Chang L, Kung J, Ding J, Chen S, Le W, Cai H.

Mol Neurodegener. 2020 Feb 19;15(1):12. doi: 10.1186/s13024-020-00360-0.

RGS proteins as critical regulators of motor function and their implications in Parkinson's disease

Ahlers-Dannen KE, Spicer MM, Fisher RA.

Mol Pharmacol. 2020 Feb 3:mol.119.118836. doi: 10.1124/mol.119.118836. Online ahead of print.

Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder

Sun J, Lai Z, Ma J, Gao L, Chen M, Chen J, Fang J, Fan Y, Bao Y, Zhang D, Chan P, Yang Q, Ye C, Wu T, Ma T.

Mov Disord. 2020 Mar;35(3):478-485. doi: 10.1002/mds.27929. Epub 2019 Dec 17.

Brain iron and metabolic abnormalities in C19orf12 mutation carriers: A 7.0 tesla MRI study in mitochondrial membrane protein-associated neurodegeneration

Dusek P, Mekle R, Skowronska M, Acosta-Cabronero J, Huelnhagen T, Robinson SD, Schubert F, Deschauer M, Els A, Ittermann B, Schottmann G, Madai VI, Paul F, Klopstock T, Kmiec T, Niendorf T, Wuerfel J,

Mov Disord. 2020 Jan;35(1):142-150. doi: 10.1002/mds.27827. Epub 2019 Sep 13.